State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma
Status:
RECRUITING
Trial end date:
2025-08-31
Target enrollment:
Participant gender:
Summary
The principal investigator for this study plans to build upon the psilocybin-assisted therapy intervention used in prior completed trials to conduct an open-label trial of two psilocybin administration sessions combined with psychotherapy to investigate the safety, tolerability, and clinical efficacy of psilocybin-assisted therapy for the treatment of PTSD in US Veterans.
Phase:
PHASE2
Details
Lead Sponsor:
Baylor College of Medicine
Collaborators:
AIM Youth Mental Health Texas Department of State Health Services Usona Institute